Best Overall Response Rate (full analysis population) | Download Table
Predicting Successful Phase Advancement and Regulatory Approval in Multiple Myeloma From Phase I Overall Response Rates | JCO Clinical Cancer Informatics
Objective response rate assessment in oncology: Current situation and future expectations
Efficacy | BALVERSA® (erdafitinib) HCP
Durable Response Rate
Response rates Overall response rate and depth of response according to... | Download Scientific Diagram
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial | Nature Medicine
RESONATE-2 - Overall Response Rate | IMBRUVICA® (ibrutinib) HCP
Efficacy Data | KYMRIAH® (tisagenlecleucel) for DLBCL | HCP
Efficacy endpoints in Oncology
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Objective response rate of placebo in randomized controlled trials of anticancer medicines - eClinicalMedicine
Visualization of efficacy endpoints in oncology clinical trials
Overall Response Rate in Previously Untreated CLL | CALQUENCE® (acalabrutinib) 100 mg tablets | For HCPs
ORR (Objective Response Rate) and related statistics – Part 1
dMMR Recurrent or Advanced Solid Tumors | JEMPERLI (dostarlimab-gxly)
Response Rates for Waldenström Macroglobulinemia Improve With Use of New First-Line, Better-Tolerated Treatments - U.S. Medicine
Overall Response Rate | CALQUENCE® (acalabrutinib) 100 mg tablets | For HCPs
Cell therapy doubles survival, response rates in advanced melanoma
BRAFTOVI + cetuximab | Overall Response Rate | ORR | BEACON CRC
Durable Response Rate
Overall response rate | Download Table
COTELLIC® (cobimetinib) + ZELBORAF® (vemurafenib) Objective Response Rate
